Laura Puigví Fernández
Laura Puigví Fernández has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Andrea Caballero
Clinical Biochemistry Department , Drug Delivery and Therapy Research Group, Vall d’Hebron Research Institute (VHIR), Vall d’Hebron University Hospital , Barcelona , Spain
3 shared publications - Berta Sufrate-Vergara
Department of Laboratory Medicine , La Paz University Hospital , Madrid , Spain
3 shared publications - Carlos García Miralles
Extraanalytical Quality Commission of the Spanish Society of Laboratory Medicine (SEQC ), Department of Clinical Biochemistry , Parc Tauli Hospital Universitari , Sabadell , Spain
3 shared publications - Débora Martínez Espartosa
Service of Biochemistry, Clínica Universidad de Navarra , Pamplona
3 shared publications Emma Ventura Orriols
Extraanalytical Quality Commission of the Spanish Society of Laboratory Medicine (SEQC ), Extraanalytical Department of Laboratory , Hospital Sant Joan de Deu, Esplugues de Llobregat , Barcelona , Spain
3 shared publications- Immaculada Comas Reixach
Extraanalytical Quality Commission of the Spanish Society of Laboratory Medicine (SEQC ), Department of Clinical Biochemistry , Vall d’Hebron Hospital , Barcelona , Spain
3 shared publications
Latest Publications
- Open Access
- 21 April 2025
- Published by Walter de Gruyter GmbH in Advances in Laboratory Medicine / Avances en Medicina de Laboratorio
- Vol. 6 (2) , 199-205
Use of external quality assessment in extra-analytical phases in clinical laboratories in Spain: a survey by the Spanish Society of Laboratory Medicine (SEQCML)
Objectives: Quality indicators (QIs) are a valuable tool for monitoring and improving extra-analytical phase performance in the clinical laboratory (CL). For that reason, the Spanish Society of Laboratory Medicine (SEQCML) launched its Pre-analytical Phase EQA Program in 2001. Methods: In 2023, a survey was conducted to assess the level of participation in the EQA Program, identify its potential improvements, and enhance the understanding of the collection and estimation processes of the extra-analytical QI. Results: In total, 51 % of respondents (124 responses in total) were enrolled in the program. The primary reason for participating was the need of monitoring of the extra-analytical phases (38 %). In contrast, the main reason for not taking part in the EQA Program was the difficulty in collecting data (32 %). As to potential points for improvement, 56 % considered that QI should be analyzed disaggregated by type of extraction (ambulatory vs. urgent). As many as 86 % of respondents would be interested in participating in a post-analytical phase EQA Program. Most of the suggestions about indicators to be included were related to events regarding temperature and transport times from peripheral extraction sites. Conclusions: Although interest in QIs for pre- and post-analytical phases is growing, the percentage of laboratories that collect data regularly is still limited. The findings of this survey have led the future directions for the EQA Pre-analytical Program, updating and adapting it to the current needs of CLs.
- 21 April 2025
- Published by Walter de Gruyter GmbH in Advances in Laboratory Medicine / Avances en Medicina de Laboratorio
- Vol. 6 (2) , 199-205
Open AccessUse of external quality assessment in extra-analytical phases in clinical laboratories in Spain: a survey by the Spanish Society of Laboratory Medicine (SEQCML)
Objectives: Quality indicators (QIs) are a valuable tool for monitoring and improving extra-analytical phase performance in the clinical laboratory (CL). For that reason, the Spanish Society of Laboratory Medicine (SEQCML) launched its Pre-analytical Phase EQA Program in 2001. Methods: In 2023, a survey was conducted to assess the level of participation in the EQA Program, identify its potential improvements, and enhance the understanding of the collection and estimation processes of the extra-analytical QI. Results: In total, 51 % of respondents (124 responses in total) were enrolled in the program. The primary reason for participating was the need of monitoring of the extra-analytical phases (38 %). In contrast, the main reason for not taking part in the EQA Program was the difficulty in collecting data (32 %). As to potential points for improvement, 56 % considered that QI should be analyzed disaggregated by type of extraction (ambulatory vs. urgent). As many as 86 % of respondents would be interested in participating in a post-analytical phase EQA Program. Most of the suggestions about indicators to be included were related to events regarding temperature and transport times from peripheral extraction sites. Conclusions: Although interest in QIs for pre- and post-analytical phases is growing, the percentage of laboratories that collect data regularly is still limited. The findings of this survey have led the future directions for the EQA Pre-analytical Program, updating and adapting it to the current needs of CLs.
- Open Access
- 3 April 2025
- Published by Walter de Gruyter GmbH in Advances in Laboratory Medicine / Avances en Medicina de Laboratorio
- Vol. 6 (2) , 206-212
Uso de la evaluación externa de la calidad en las fases extraanalíticas de los laboratorios clínicos españoles: una encuesta de la Sociedad Española de Medicina de Laboratorio (SEQCML)
Resumen: Objetivos: La gestión de indicadores de calidad (IC) es una herramienta óptima para monitorizar y mejorar el desempeño en las fases extraanalíticas del Laboratorio Clínico (LC). Por este motivo, la Sociedad Española de Medicina de Laboratorio (SEQCML) lanzó en 2001 el Programa de Preanalítica. Métodos: En 2023 se realizó una encuesta para evaluar el grado de participación en el Programa y valorar la necesidad de mejora, así como conocer el procedimiento de la recogida y cálculo de IC extraanalíticos. Resultados: El 51 % de los encuestados (124 respuestas en total) participaba en el Programa, y el motivo más importante para hacerlo era porque se considera necesario monitorizar las fases extraanalíticas (38 %). Por el contrario, la principal razón para no participar fue la dificultad para recoger los datos (32 %). Respecto a las necesidades de mejora del Programa, el 56 % considera útil la revisión de indicadores disgregada por tipo de extracción (ambulatoria vs. urgente) y el 86 % tendría interés en participar en un programa de postanalítica. En cuanto a otros indicadores interesantes para ser incluidos, la mayoría se relacionaban con incidencias en los tiempos y temperaturas de transporte desde centros de extracción periféricos. Conclusiones: Existe un creciente interés en los IC relacionados con las fases pre y postanalíticas, sin embargo, un número reducido de laboratorios obtienen datos completos con regularidad. Los hallazgos de esta encuesta han permitido guiar las futuras ampliaciones del Programa de Preanalítica para adaptarse a las necesidades actuales de los LC.
- 3 April 2025
- Published by Walter de Gruyter GmbH in Advances in Laboratory Medicine / Avances en Medicina de Laboratorio
- Vol. 6 (2) , 206-212
Open AccessUso de la evaluación externa de la calidad en las fases extraanalíticas de los laboratorios clínicos españoles: una encuesta de la Sociedad Española de Medicina de Laboratorio (SEQCML)
Resumen: Objetivos: La gestión de indicadores de calidad (IC) es una herramienta óptima para monitorizar y mejorar el desempeño en las fases extraanalíticas del Laboratorio Clínico (LC). Por este motivo, la Sociedad Española de Medicina de Laboratorio (SEQCML) lanzó en 2001 el Programa de Preanalítica. Métodos: En 2023 se realizó una encuesta para evaluar el grado de participación en el Programa y valorar la necesidad de mejora, así como conocer el procedimiento de la recogida y cálculo de IC extraanalíticos. Resultados: El 51 % de los encuestados (124 respuestas en total) participaba en el Programa, y el motivo más importante para hacerlo era porque se considera necesario monitorizar las fases extraanalíticas (38 %). Por el contrario, la principal razón para no participar fue la dificultad para recoger los datos (32 %). Respecto a las necesidades de mejora del Programa, el 56 % considera útil la revisión de indicadores disgregada por tipo de extracción (ambulatoria vs. urgente) y el 86 % tendría interés en participar en un programa de postanalítica. En cuanto a otros indicadores interesantes para ser incluidos, la mayoría se relacionaban con incidencias en los tiempos y temperaturas de transporte desde centros de extracción periféricos. Conclusiones: Existe un creciente interés en los IC relacionados con las fases pre y postanalíticas, sin embargo, un número reducido de laboratorios obtienen datos completos con regularidad. Los hallazgos de esta encuesta han permitido guiar las futuras ampliaciones del Programa de Preanalítica para adaptarse a las necesidades actuales de los LC.
- 25 March 2025
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 63 (8) , 1620-1631
Consensus instability equations for routine coagulation tests
Objectives: The stability of plasma samples for basic coagulation tests, prothrombin time (PT) and activated partial thromboplastin time (aPTT), has been widely studied. Recently, the Clinical and Laboratory Standards Institute (CLSI) updated its recommendations, extending the acceptable time frame for aPTT. These guidelines are based on experimental studies, which define limits according to different maximum permissible error (MPE) criteria. This study compiles raw data from 43 studies published over the last 30 years to develop a consensus instability equation that describes degradation independently of specific study parameters. Methods: A critical literature review was performed by collecting studies that included experimental stability data for PT, aPTT and the main procoagulant factors. The raw data of percentage deviation (PD%), time, and seven classification variables related to sample collection and handling were analysed. A regression model through the origin was applied to derive global instability equations and to assess influencing variables. Results: In frozen samples, PT and aPTT showed similar stability, with an average prolongation of 0.8 % per month. In non-frozen samples, tube handling affected stability more than storage temperature. The consensus equation for PT showed a linear average deterioration of 2.9 % per day, but model strength was limited. For aPTT, the consensus equation fitted better to a logarithmic decay model and predicted prolongations of 6.1 and 10 % at 6 and 24 h, respectively. Conclusions: The consensus instability equations obtained in this review provide a robust model for assessing coagulation tests stability, aligning with expert recommendations. These equations improve the understanding of sample degradation and systematic error quantification.
- 25 March 2025
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 63 (8) , 1620-1631
Consensus instability equations for routine coagulation tests
Objectives: The stability of plasma samples for basic coagulation tests, prothrombin time (PT) and activated partial thromboplastin time (aPTT), has been widely studied. Recently, the Clinical and Laboratory Standards Institute (CLSI) updated its recommendations, extending the acceptable time frame for aPTT. These guidelines are based on experimental studies, which define limits according to different maximum permissible error (MPE) criteria. This study compiles raw data from 43 studies published over the last 30 years to develop a consensus instability equation that describes degradation independently of specific study parameters. Methods: A critical literature review was performed by collecting studies that included experimental stability data for PT, aPTT and the main procoagulant factors. The raw data of percentage deviation (PD%), time, and seven classification variables related to sample collection and handling were analysed. A regression model through the origin was applied to derive global instability equations and to assess influencing variables. Results: In frozen samples, PT and aPTT showed similar stability, with an average prolongation of 0.8 % per month. In non-frozen samples, tube handling affected stability more than storage temperature. The consensus equation for PT showed a linear average deterioration of 2.9 % per day, but model strength was limited. For aPTT, the consensus equation fitted better to a logarithmic decay model and predicted prolongations of 6.1 and 10 % at 6 and 24 h, respectively. Conclusions: The consensus instability equations obtained in this review provide a robust model for assessing coagulation tests stability, aligning with expert recommendations. These equations improve the understanding of sample degradation and systematic error quantification.